Interleukin-6 receptor blockade for the treatment of NMOSD

Lancet Neurol. 2020 May;19(5):370-371. doi: 10.1016/S1474-4422(20)30081-8.
No abstract available

Publication types

  • Comment

MeSH terms

  • Aquaporin 4
  • Double-Blind Method
  • Humans
  • Immunosuppressive Agents
  • Neuromyelitis Optica*
  • Receptors, Interleukin-6

Substances

  • Aquaporin 4
  • Immunosuppressive Agents
  • Receptors, Interleukin-6